Then, our RNA sequencing and chromatin immunoprecipitation sequencing experiments using the basal-like breast cancer cell lines BT549 and Hs578T with FOXD1 knockdown revealed that FOXD1 regulates enhancer–gene programs related to tumor progression. The gene discussed is FOXD1; the disease is breast cancer.